Regarding the paper: Hydroview lens implant calcification—186 exchanges at a district general hospital, by P Syam et al

Tetz, M.; Werner, L.
March 2008
Eye;Mar2008, Vol. 22 Issue 3, p323
Academic Journal
The author reflects on the study which discusses an experience at a district hospital with 174 consecutive intraocular lenses (IOL) exchanges because of calcification of the Hydroview lens from Bausch & Lamb Inc. The author mentions the first calcified exchange in 2002, with the onset of symptoms due to the calcification after 260 weeks from implantation. Furthermore, the author commented on the results of the research and gave some suggestions related to postoperative complications.


Related Articles

  • Cause of IOL calcifications still under investigation. Charters, Lynda // Ophthalmology Times;11/01/2000, Vol. 25 Issue 21, p3 

    Reports on the status of the Hydroview IOL lenses from Bausch & Lomb in connection with lens calcification investigation. Multifactorial cause of the calcification; Actions taken by the company; Information on several cases of calcification.

  • Study documents IOL efficacy. Krader, Cheryl Guttman; Behndig, Anders // Ophthalmology Times;5/15/2010, Vol. 35 Issue 10, p24 

    The article discusses a clinical study on the Akreous MI60 microincisional intraocular lens (IOL) from Bausch + Lomb Inc., which showed favorable performance of the lens. The study participants exhibited a wide range of cataract density. During the process, the IOL was implanted using a...

  • Hydrophilic acrylic shows stability. Charters, Lynda // Ophthalmology Times;7/1/2007, Vol. 32 Issue 13, p18 

    The article offers information regarding the implantation of microincision intraocular lenses (IOL). According to physician Roberto Bellucci, the new microincision IOL by Bausch & Lomb Inc. can be implanted through a 2 mm incision and offers stability, efficacy and produces same results like...

  • Unique Initiative Perfects Vision and Enhances Life. Corley, Andy // Profiles in Diversity Journal;Jul/Aug2008, Vol. 10 Issue 4, p22 

    The article reports on the unique program called Changing 100 Lives in 100 Minutes sponsored by Bausch & Lomb Inc. (B&L) in the U.S. It states that the program was developed to mark the implantation of B&L's 100,000th crystalens, an intraocular lens. It adds that the program succeed the...

  • Aberration-free lens outperforms two other lenses. Nichamin, Louis // Ophthalmology Times;5/15/2007, Vol. 32 Issue 10, p18 

    The article evaluates the aberration-free aspheric silicone intraocular lens SoftPort Advanced Optics by Bausch & Lomb Inc.

  • FDA approves hydrophobic acrylic IOL. Krader, Cheryl Guttman // Ophthalmology Times;7/15/2012, Vol. 37 Issue 14, p1 

    The article offers brief information on intraocular lens (IOL) from Bausch + Lomb.

  • Bausch + Lomb launches hydrophobic acrylic toric IOL for astigmatism. Boyle, Erin L.; Cimberle, Michela // Ocular Surgery News Europe;Oct2012, Vol. 23 Issue 9, p17 

    The article introduces the en Vista toric hydrophobic acrylic intraocular lens (IOL) from Bausch + Lomb.

  • The Crystalens Goes Aberration-Free.  // Review of Optometry;3/15/2010 Part 1 of 2, Vol. 147 Issue 3, p140 

    The article evaluates the aspheric optic Crystalens AO intraocular lenses from Bausch+Lomb Inc.

  • Accommodating platform offers benefits for presbyopic correction. Krader, Cheryl Guttman; Lindstrom, Richard L. // Ophthalmology Times;5/15/2010, Vol. 35 Issue 10, p20 

    The article evaluates the Crystalens HD accomodating intraocular lens (IOL) from Bausch + Lomb Inc.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics